Effects of gyrase mutation on the growth kinetics of ciprofloxacin- resistant strains of Clostridium perfringens

Anaerobe

Volumn 11, Issue 4, 2005, Pages 201-205

  Rafii, Fatemeh ^a   Park, Miseon ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Clostridium perfringens; Fluoroquinolones; Gyrase; Mutation; Resistance

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE; GATIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESERPINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM MUTANT; CELL DENSITY; CLOSTRIDIUM PERFRINGENS; DRUG EFFECT; MINIMUM INHIBITORY CONCENTRATION; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); CLOSTRIDIUM PERFRINGENS;

EID: 19444363874     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2005.01.004     Document Type: Article

References (16)

1. D.W. Hecht Prevalence of antibiotic resistance in anaerobic bacteria: worrisome development Clin Infect Dis 39 2004 92 97
2. E.J.C. Goldstein, D.M. Citron, M. Hudspeth, S.H. Gerardo, and C.V. Merriam Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens J Antimicrob Chemother 41 1998 391 396
3. Y. Golan, L.A. McDermott, N.V. Jacobus, E.J. Goldstein, S. Finegold, L.J. Harrell, D.W. Hecht, S.G. Jenkins, C. Pierson, R. Venezia, J. Rihs, P. Iannini, S.L. Gorbach, and D.R. Snydman Emergence of fluoroquinolone resistance among Bacteroides species J Antimicrob Chemother 52 2003 208 213
4. K. Drlica, and D. Hooper Mechanism of quinolone actions D. Hooper E. Rubinstein The quinolones 2003 American Society for Microbiology Washington, DC 19 40
5. K. Drlica, and M. Malik Fluoroquinolones: action and resistance Curr Top Med Chem 3 2003 249 282
6. L. Martinez-Martinez, A. Pascual, and G.A. Jacoby Quinolone resistance from a transferable plasmid Lancet 351 1998 797 799
7. S. Miyamae, O. Ueda, F. Yoshimura, J. Hwang, Y. Tanaka, and H. Nikaido A MATE family multidrug efflux transporter pumps out fluoroquinolones in Bacteroides thetaiotaomicron Antimicrob Agents Chemother 45 2001 3341 3346
8. M.L. Peterson, J.C. Rotschafer, and L.J. Piddock Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilis J Antimicrob Chemother 52 2003 481 484
9. G. Ackermann, Y.J. Tang, R. Kueper, P. Heisig, A.C. Rodloff, J. Silva Jr, and S.H. Cohen Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA Antimicrob Agents Chemother 45 2001 2348 2353
10. R. Alonso, T. Pelaez, M.J. Gonzalez-Abad, L. Alcala, P. Munoz, M. Rodriguez-Creixems, and E. Bouza In vitro activity of new quinolones against Clostridium difficile J Antimicrob Chemother 47 2001 195 197
11. F. Rafii, and E.B. Hansen Jr Isolation of nitrofurantoin-resistant mutants of nitroreductase-producing Clostridium sp. strains from the human intestinal tract Antimicrob Agents Chemother 42 1998 1121 1126
12. NCCLS (National Committee for Clinical Laboratory Standards) Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard. Sixth ed. NCCLS document M11-A6 2004 National Committee for Clinical Laboratory Standards Wayne, PA
13. R.N. Jones, M.E. Erwin, and J.L. Croco Critical appraisal of E test for the detection of fluoroquinolone resistance J Antimicrob Chemother 38 1996 21 25
14. F. Rafii, M.S. Park, and J.S. Novak Alterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones Antimicrob Agents Chemother 49 2005 488 492
15. T. Lu, X. Zhao, and K. Drlica Gatifloxacin activity against quinolone-resistant gyrase: allele-specific enhancement of bacteriostatic and bactericidal activities by the C-8-methoxy group Antimicrob Agents Chemother 43 1999 2969 2974
16. C.M. Perry, J.A. Barman Balfour, and H.M. Lamb Gatifloxacin Drugs 58 1999 683 698